Anti‐tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL‐302 in neuroblastoma. Issue 1 (9th January 2020) - Mohlin, Sofie; Hansson, Karin; Radke, Katarzyna; Martinez, Sonia; Blanco‐Aparicio, Carmen; Garcia‐Ruiz, Cristian; Welinder, Charlotte; Esfandyari, Javanshir; O'Neill, Michael; Pastor, Joaquin; von Stedingk, Kristoffer; Bexell, Daniel